Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_assertion type Assertion NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_head.
- NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_assertion description "[MC1R Val92/Val92 and VDR ff were associated with increased risk of metastases (ORs 4.30 and 4.98, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_provenance.
- NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_assertion evidence source_evidence_literature NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_provenance.
- NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_assertion SIO_000772 11532853 NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_provenance.
- NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_assertion wasDerivedFrom befree-20140225 NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_provenance.
- NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_assertion wasGeneratedBy ECO_0000203 NP802825.RAOdbtp49VXfk6RjJaVhwBJIeL73rNlAXq_UHz5fIIp0U130_provenance.